"Breakthrough FDA-approved drug offers hope for menopausal women suffering from hot flashes"
The U.S. Food and Drug Administration has approved a new non-hormonal drug called Veozah (fezolinetant) for the treatment of hot flashes and night sweats in menopausal women. Veozah works by blocking a chemical in the brain that regulates body temperature, providing relief from vasomotor symptoms. It is particularly beneficial for women who cannot take hormone replacement therapy due to estrogen-sensitive cancers or other health conditions. Studies have shown that Veozah reduces hot flashes and night sweats as early as the first day of use. The drug is expected to have a significant impact on women's quality of life, especially for women of color who tend to experience more severe symptoms. However, long-term effects and cost considerations still need to be further studied and addressed.